ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lamotrigine assay, fentanyl assay, zonisamide assay, methotrexate assay, thyroxine assay and entry inhibitor, among others. Its products are used in the therapeutic areas of epilepsy, pain management, cancer, urine tests, veterinary, and HIV or AIDS. ARK Diagnostics's protease inhibitors include ritonavir, darunavir, saquinavir, amprenavir, lopinavir, atazanavir, indinavir and tipranavir. The company's immunoassays measure drug levels in biological fluids that enable clinicians to guide dosing decisions for drug therapy. It distributes its products across Germany, Austria, Belgium, the Netherlands, Luxembourg, the UK and Ireland. ARK Diagnostics is headquartered in Fremont, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ARK Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ARK Diagnostics Inc Company Overview
- ARK Diagnostics Inc Company Snapshot
- ARK Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- ARK Diagnostics Inc - Pipeline Analysis Overview
- ARK Diagnostics Inc - Key Facts
- ARK Diagnostics Inc - Major Products and Services
- ARK Diagnostics Inc Pipeline Products by Development Stage
- ARK Diagnostics Inc Pipeline Products Overview
- ARK Apixaban Assay
- ARK Apixaban Assay Product Overview
- ARK Atazanavir Assay
- ARK Atazanavir Assay Product Overview
- ARK Dabigatran Assay
- ARK Dabigatran Assay Product Overview
- ARK Darunavir Assay
- ARK Darunavir Assay Product Overview
- ARK Dolutegravir Assay
- ARK Dolutegravir Assay Product Overview
- ARK Edoxaban Assay
- ARK Edoxaban Assay Product Overview
- ARK High Sensitivity Opiates Assay
- ARK High Sensitivity Opiates Assay Product Overview
- ARK Indinavir Assay
- ARK Indinavir Assay Product Overview
- ARK Lopinavir Assay
- ARK Lopinavir Assay Product Overview
- ARK Maraviroc Assay
- ARK Maraviroc Assay Product Overview
- ARK Nelfinavir Assay
- ARK Nelfinavir Assay Product Overview
- ARK Nevirapine Assay
- ARK Nevirapine Assay Product Overview
- ARK Perampanel Assay
- ARK Perampanel Assay Product Overview
- ARK Rivaroxaban Assay
- ARK Rivaroxaban Assay Product Overview
- ARK Saquinavir Assay
- ARK Saquinavir Assay Product Overview
- ARK Tiagabine Assay
- ARK Tiagabine Assay Product Overview
- ARK Zolpidem Assay
- ARK Zolpidem Assay Product Overview
- ARK Zopiclone Assay
- ARK Zopiclone Assay Product Overview
- ARK Diagnostics Inc - Key Competitors
- ARK Diagnostics Inc - Key Employees
- ARK Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- ARK Diagnostics Inc, Recent Developments
- Jan 04, 2024: ARK Diagnostics Receives 510(K) Clearance For Methotrexate II Assay
- Nov 22, 2023: ARK Diagnostics Receives 510(K) Clearance For ARK Hydrocodone Assay
- Aug 10, 2021: ARK Diagnostics receives 510(k) clearance for ARK Lacosamide Assay
- Jul 06, 2021: Orient Gene won the lawsuit in the Section 337 Investigation of Gabapentin immunoassay products
- Jan 15, 2020: Siemens Healthineers adds fentanyl assay to its menu to help laboratories address greater demand for opioid testing
- Oct 17, 2014: Roche to integrate Methotrexate test from ARK Diagnostics into therapeutic drug monitoring menu for clinical chemistry analyzers
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ARK Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- ARK Diagnostics Inc Pipeline Products by Equipment Type
- ARK Diagnostics Inc Pipeline Products by Indication
- ARK Diagnostics Inc, Key Facts
- ARK Diagnostics Inc, Major Products and Services
- ARK Diagnostics Inc Number of Pipeline Products by Development Stage
- ARK Diagnostics Inc Pipeline Products Summary by Development Stage
- ARK Apixaban Assay - Product Status
- ARK Apixaban Assay - Product Description
- ARK Atazanavir Assay - Product Status
- ARK Atazanavir Assay - Product Description
- ARK Dabigatran Assay - Product Status
- ARK Dabigatran Assay - Product Description
- ARK Darunavir Assay - Product Status
- ARK Darunavir Assay - Product Description
- ARK Dolutegravir Assay - Product Status
- ARK Dolutegravir Assay - Product Description
- ARK Edoxaban Assay - Product Status
- ARK Edoxaban Assay - Product Description
- ARK High Sensitivity Opiates Assay - Product Status
- ARK High Sensitivity Opiates Assay - Product Description
- ARK Indinavir Assay - Product Status
- ARK Indinavir Assay - Product Description
- ARK Lopinavir Assay - Product Status
- ARK Lopinavir Assay - Product Description
- ARK Maraviroc Assay - Product Status
- ARK Maraviroc Assay - Product Description
- ARK Nelfinavir Assay - Product Status
- ARK Nelfinavir Assay - Product Description
- ARK Nevirapine Assay - Product Status
- ARK Nevirapine Assay - Product Description
- ARK Perampanel Assay - Product Status
- ARK Perampanel Assay - Product Description
- ARK Rivaroxaban Assay - Product Status
- ARK Rivaroxaban Assay - Product Description
- ARK Saquinavir Assay - Product Status
- ARK Saquinavir Assay - Product Description
- ARK Tiagabine Assay - Product Status
- ARK Tiagabine Assay - Product Description
- ARK Zolpidem Assay - Product Status
- ARK Zolpidem Assay - Product Description
- ARK Zopiclone Assay - Product Status
- ARK Zopiclone Assay - Product Description
- ARK Diagnostics Inc, Key Employees
- Glossary
- ARK Diagnostics Inc Pipeline Products by Equipment Type
- ARK Diagnostics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A/C Diagnostics LLC
- Kestrel Biosciences LLC
- Advanced Cell Diagnostics Inc
- A/C Diagnostics LLC
- Advanced Cell Diagnostics Inc
